Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and aged 18 or older
- People whose doctors expect them to live for at least 12 weeks
- People who are fully active or have only minor restrictions in physical activity (this is measured using a standard scale called ECOG, scored 0 or 1)
- People who have been diagnosed through a tissue biopsy with invasive breast cancer that has spread or cannot be cured or surgically removed
- People who have at least one tumour that can be measured using standard imaging guidelines (called RECIST 1.1)
- People who have not previously been treated with a type of medication called an antibody-drug conjugate
- People who have received no more than one previous chemotherapy treatment for advanced breast cancer
- People whose tumour has been tested for hormone receptor status — those with hormone receptor-positive cancer may have had up to two previous hormone-based treatments for advanced disease
- People whose breast cancer is classified as "HER2-low" or "HER2-ultralow" based on specific laboratory test results (confirm with trial site for exact test details)
- People whose kidneys, liver, blood, and other organs are functioning well enough to meet the trial's requirements
Who may not be able to join:
- People who have a history of blood clots in veins or arteries
- People who have uncontrolled ongoing health conditions such as diabetes, high blood pressure, lung disease, or liver cirrhosis
- People who have an active infection that requires treatment with medication
- People who are currently pregnant or breastfeeding
- People who have cancer that has spread to the brain or the lining around the brain or spinal cord
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wenjin Yin, M.D., Renji Hospital,School of Medicine, Shanghai Jiaotong University
Phone: 86(21)68385569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.